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Application of Log-Linear Model in
Inference on Karyotypic Evolution in
Chronic Myelocytic Leukemia
by Tetsuo Hashimoto,* Megu Ohtaki,* Nanao Kamada,*
Hisashi Yamamoto,t and Masaki Munaka*
Relationships among additional chromosome abnormalities in chronic myelocytic leukemia (CML) with
translocation 9;22 [Philadelphia chromosome (Ph')-positive CMLI were analyzed by log-linear models on
709 karyotypes reported in the literature. Additional abnormalities, such as the gain of chromosome 8
(+8), gain of Philadelphia chromosome (+Ph'), isochromosome of the long arm (q) of chromosome 17
[i(17q)], and the gain of chromosome 19 (+19), were frequently observed. A four-way 2 x 2 x 2 x 2
contingency table was considered with respect to the appearance of these four abnormalities, then the
hierarchical log-linear models having at least four main effects were fitted to the observed contingency
table. Akaike's information criteria ofthe models reflected the fitness of the model very well. Parameter
estimates of the interaction terms indicated that the combinations of two abnormalities, '+8 and +19',
' +Ph' and +19', and '+8 and i(17q)' were positively associated, while '+Ph' and i(17q)', and '+19 and
i(17q)' were negatively associated. Based on the results of the data analysis, an inference was made on
the route of karyotypic evolution in Ph'-positive CML; it statistically supports the hypothesis presented
by Heim and Mitelman.
Introduction
The translocation 9;22 found in the karyotypes of
chronic myelocytic leukemia (CML) patients is strongly
associated with CML as a specific chromosome abnor-
mality. It is regarded as a primary abnormality that
plays afundamental role in initiating the malignant pro-
cess ofCML (1). Additional chromosome abnormalities
superimposed on the translocation 9;22, such as
+Ph1[j+22q-, +del(22)(qll), etc.], +8 and/or i(17q)
also occur in most patients with CML in blastic crisis.
These abnormalities reflect the karyotypic evolution of
malignant cells in vivo (2-4).
Heim and Mitelman (4) presented ahypothesis ofkar-
yotypic evolution in CML patients by analyzingthe pat-
terns of additional chromosome abnormalities other
than translocation 9;22. The major route of karyotypic
evolution bytheirhypothesis was asfollows: +8, +Ph1,
or i(17q) are the main additional changes after a trans-
location 9;22 occurs; +19, on the other hand, seems to
occur later in karyotypic evolution, most often in com-
bination with both +8 and +Ph1; i(17q) in combination
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with +8 is a quite frequent phenomenon, whereas the
combinations 'i(17q) and + 19', '+Ph' and i(17q)', '+8,
i(17q), and + 19', and '+Ph1, i(17q), and +19' are only
seen very rarely. These findings testify to the fact that
i(17q)apparentlyhasarestrictiveroleinthecytogenetic
evolution in CML, at least when no extra chromosome
8 is present in the cells. The hypothesis, however, is
derived from single-column freq1uencies ofcombinations
of abnormalities, such as '+Ph and +8' and '+8 and
i(17q)', without analysis of associations among addi-
tional abnormalities.
In the present study, we analyzed 709 cases of Ph1
positive CML karyotypes with additional abnormalities
that were derived from the same database ofMitelman
et al. (4) and quantified the relationships among addi-
tional abnormalities by means of multivariate analysis
of frequency table (log-linear models).
Materials and Methods
The material used in this study consisted of 709 Ph1-
positive CML karyotypeswithadditionalabnormalities,
which were collected from the Catalog ofChromosome
Aberrations in Cancer, second edition (5). Single-col-
umn frequencies of the additional abnormalities were
analyzed by ourpreviously reported computer program
(6-8). A four-way 2 x 2 x 2 x 2 contingency table
where the four indices pertain to categorical (none orHASHIMOTO ET AL.
present) variables A: +8, B: +Ph', C: i(17q), and D:
+19 was considered, and then log-linear models (9)
were fitted to the observed four-way contingency table.
The analysis contained 113 hierarchical models with at
least fourmain effects; asaturated model was excluded.
For example, the model only with four main effects,
that is, the independent model, is,
log mijkl = + At + + +
[A,B,C,D] (Model 1)
where mijk1 is the expected value of observed cell fre-
quency and , and X's values are unknown parameters.
The model with four main effects and six terms of
two-way interactions, that is, the second-order full
model, is:
log m1i,kl = 1F + At+ Aj + Ak+ Al'
+ A + AC +XC + X C
+ BD ACD
[AB,AC,AD,BC,BD,CD] (Model 80).
The model with four main effects, six terms of two-
way interactions, and four terms of three-way inter-
actions, that is, the third order full model, is:
log mijkl R + XAt + XjB + 4C + AD
+ Aj + AiC + i + jk
+ XBD + XCD
+ XABC + ABD +ACD + \BCD + A ijk ijA Dikl 1jk
[ABC,ABD,ACD,BCD] (Model 113).
To evaluate the goodness of the fit for 113 models,
Akaike's information criteria (AIC) (10) was calculated
for each model:
AIC = G- 2df
where G2, dfrepresents the likelihood ratio chi-square,
the degrees of freedom, of the model, respectively.
Generally, twomodelsMl andM2 are saidtobenested
if all ofthe X effects in Ml are a subset of the X values
contained in M2. Conditioning the effects in Ml, the
difference in G' between the Ml and the M2 is the test
ofthe additional effects in M2. This difference also has
an asymptotic chi-square distribution with degrees of
freedom equal to the difference in the number of pa-
rameters fitted to the two models. Therefore, to test
the significance of two- or three-way interactions, the
difference in the G2 between one model and the other
model which does not contain the attended interaction
was computed. The program package BMDP (11) was
used for these analyses.
Results and Discussion
Additional chromosome abnormalities frequently
found in the 709 karyotypes from Ph'-positive CML
patients were +8 (253 cases, 35.6%), +Ph' (238 cases,
33.5%), i(17q) (184 cases, 25.9%), +19 (109 cases,
15.3%), +21 (48 cases, 6.7%), +17 (44 cases, 6.2%),
+10 (29 cases, 4.0%), -7 (28 cases, 3.9%), and -Y (17
cases, 2.3%). All of the other additional abnormalities
were less than 2% of 709 cases.
Table 1 shows the 2 x 2 x 2 x 2 contingency table
with respect to the presence offour main abnormalities
(+8, +Ph1, i(17q), and +19). The table contains the
raw data ofthis analysis.
Table 2 summarizes the degrees offreedom (dj), like-
lihood ratio chi-square (LR X ), and the AIC ofthe 113
hierarchicalmodelsatleastwithfourmaineffects. AICs
are graphically plotted on the right-hand side of the
table. Of all the 113 AICs, 19 AICs were less than 0.
The maximum and minimum values ofAIC were 188.49
in Model 1 (the independent model) and -5.68 in Model
103. In the models with one or two terms of two-way
interactions (Models 2 through 22), all ofthe AICs were
greaterthan 50. In the models with three terms oftwo-
way interactions (Models 23 through 42), the model
[AD,BC,BD] (Model 39) (which has the interactions of
'A: +8 and D: + 19', 'B: +Ph' and C: i(17q)', and 'B:
+Ph1 and D: +19') indicated the lowest AIC value
(11.01). In the models with four terms of two-way in-
teractions (Models 43 through 57), [AC,AD,BC,BD]
(Model 53) and [AD,BC,BD,CD] (Model 57) (both of
which have the terms, AD, BC, and BD included in
Model 39) indicated lower AIC values than other
models-thatis, 5.65 and 6.36, respectively. These two
models have no two-way interaction of 'A: +8 and B:
+Ph". Comparison of the AICs of both [AD,BC,BD]
(Model 39) and [AB,AD,BC,BD] (Model 49) indicates
that the two-way interaction ofAB does not contribute
to increase a fitness. In the models with five terms of
two-way interactions (Models 62 through 67),
[AC,AD,BC,BD,CD] (Model 67) was the best with an
AIC value of -2.93. TheAIC wasespeciallylowerthan
other models, and it was the tenth lowest value of all
the 113 AICs. The AIC ofthe second-order full model
(Model80) was -3.69, which wasthefifth lowest value.
In the models with five terms of two-way interactions
and one or two of three-way interactions (Models 81
through 98), Models 89, 92, and 98 (which lacked the
two-way term AB) indicated especially lower AIC val-
ues than others, that is, -1.11, -1.46, and 0.36, re-
Table 1. Observed frequency table with respect to the presence
offour main abnormalities (raw data ofthe analysis).
Presence of abnormalities +8 N" +8 pb Total
+ 19 N i(17q) N +Ph' N 207 65 272
+Ph' P 106 47 153
Total 313 112 425
i(17q) P +Ph' N 102 60 162
+Ph' P 4 9 13
Total 106 69 175
+ 19 P i(17q) N +Ph' N 9 22 31
+Ph' P 27 42 69
Total 36 64 100
i(17q) P +Ph' N 1 5 6
+Ph' P 0 3 3
Total 1 8 9
'N: none. bp: present.
136LOG-LINEAR APPLICATIONS TO CHROMOSOME ABNORMALITIES
Table 2. Degree of freedom (df), likelihood ratio chi-square (LRX2), and Akaike's information criteria (AIC) of the 113 hierarchical
models at least with four main effects.
Model Value ofAIC
no.a (A,B,C,D +) df LRX2 AIC 0 5 10 50 100 200
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spectively. These three AICs, the AIC of
[AC,AD,BC,BD,CD] (Model 67), and several previous
results suggest that the appearance of A: +8 and B:
+Ph' tend to be independent. All the models with six
terms oftwo-way interactions and one or more ofthree-
wayinteractions(Models 99through 113) hadlowerAIC
valuesthan0. Inthesemodels, themodelwith sixterms
of two-way interactions and two of three-way interac-
tions [CD,ABC,ABD] (Model 103), indicated aminimum
AIC value of all the 113 AICs. The models with six
terms of two-way interactions and one of three-way
interaction, [AD,BD,CD,ABC] (Model 99) and
[AC,BC,CD,ABD] (Model 100), had the second and the
third lowest AICs, respectively.
Table 3 shows the expected frequencies by Models 1,
80, and 103. No good fitness was found between ob-
served frequencies [0] and expected frequencies [E] by
the independent model only with four main effects
(Model 1). For example, the value of[O]I[E] - 1, which
indicates the deviation of [0] from [E], was +3.15 on
the cell, corresponding to the presence of ' +8, +Ph',
and + 19' (pattern 7). It means that the expected fre-
quency [E] was underestimated. Conversely, the value
of [O]I[E] - 1 was -0.74 on the cell of ' + 19' (pattern
10), meaning that [E] was overestimated. Therefore,
the presence of +19 may not be explained without con-
sideringtheinteractionsofmore thantwofactors. How-
ever, the fitness of [0] and [E] by the second-order full
model (Model 80) was considerably improved, and the
values of [O]f[E] - 1 closed with 0. The values of [O]l
[E]
- 1 with the best modelregarding AIC (Model 103)
were nearly 0. The fitness was very good.
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Table 2. Continued.
Model Value of AICb
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aIn a hierarchical model, a higher effect cannot be present unless all lower order effects whose indices are subsets ofthe higher order effect are also included
in the model: e.g. if XABC is stated (nonzero), it means that ,u, XA, XB, XC, XB, XAC, XBC are all present. All effects other than four main ones are described in the
left-hand side of the column. Since only hierarchical models are considered in this analysis models are also described by a minimal set of effects in parentheses.
For example, the full second-order model (Model 80) includes the terms ,± XA, XB, XC V, XAB, XAC, XAD, \BC, XBD, and XCD, while all the interactions of three
or four factors set to 0. This model can be described by the minimal set ofeffects [AB,AC,AD,BC,BR,CD].
bNumbers by the symbols (.) represent the order ofAIC from the minimum value.
Parameter estimates of the cells that correspond to
'presence', 'presence and presence', or 'presence and
presence and presence' of one, two, or three abnor-
malities were shown in Table 4 as the values of 1B =
exp(M). Concerning the six interactions of a given two
factors, if the value of parameter
A is greater than 1,
the two factors are considered to be positively corre-
lated to each other. On the other hand, if
A is smaller
than 1, a negative correlation is suggested between the
two factors. Then the parameter estimates and the re-
sults ofsignificance tests on Model 80 indicate that '+8
and i(17q)', '+8 and + 19', and '+Ph' and +19' were
significantly positively associated, while '+22q- and
i(17q)' and '+ 19 and i(17q)' were significantly nega-
tively associated. The parameter estimates ofthe two-
way interactions in the second-order full model (Model
80) was not greatly different from those in the third-
order full model (Model 113), and then the parameter
estimates of the three-way interactions in the third-
order full model (Model 113) and the best model (Model
103) were nearly 1. Therefore, the four-way 2 x 2 x
2 x 2 contingency table is considered to be fully ex-
plained by the second-order full model (Model 80). Fur-
thermore, the second-order model, which only lacks a
two-way term AB (Model 67), is also considered to be
a reasonable model.
With regard to the cell of '+8, +Ph1, + 19', the ob-
served frequency was quite higher than the expected
value by the independent model (Model 1), as shown in
pattern 7 in Table 3. The high frequency ofthe pattern
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Table 3. Observed [0] and expected [E] frequencies of four-way 2x2 x2x2 contingency table.
Abnormalitiesa Observed Model lb Model 80C Model 103d
Pattern frequency (%)
number + 8 +Ph' i(17q) + 19 [0] [E] [O]/[E]- 1 [El [O]/[E]- 1 [E] [O]/[E]- 1
1 - - _ _ 207(29.1) 189.4 + 0.09 207.9 - 0.00 207.5 - 0.00
2 - + _ - 106(14.9) 96.5 + 0.09 106.7 - 0.00 106.4 - 0.00
3 - - + - 102(14.3) 67.3 + 0.51 98.4 + 0.03 102.5 - 0.00
4 + - - - 65( 9.1) 105.8 - 0.38 66.1 - 0.01 66.2 - 0.01
5 + - + - 60( 8.4) 37.6 + 0.59 63.6 - 0.05 59.8 + 0.00
6 + + - - 47( 6.6) 53.9 - 0.12 46.3 + 0.01 46.9 + 0.00
7 + + - + 42( 5.9) 10.1 + 3.15 47.2 - 0.11 43.1 - 0.02
8 - + - + 27( 3.8) 18.1 + 0.49 23.8 + 0.13 27.6 - 0.02
9 + - - + 22( 3.1) 19.8 + 0.11 18.4 + 0.19 21.8 + 0.00
10 - - - + 9( 1.2) 35.4 - 0.74 12.6 - 0.28 9.5 - 0.05
11 + + + - 9( 1.2) 19.2 - 0.53 7.0 + 0.28 10.1 - 0.10
12 + - + + 5( 0.7) 7.0 - 0.28 6.0 - 0.16 6.2 - 0.19
13 - + + - 4( 0.5) 34.3 - 0.88 8.0 - 0.50 4.6 - 0.13
14 + + + + 3( 0.4) 3.6 - 0.16 2.4 + 0.25 2.9 + 0.03
15 - - + + 1( 0.1) 12.6 - 0.92 2.0 - 0.50 1.5 - 0.33
16 - + + + 0( 0.0) 6.4 - 1.00 0.6 - 1.00 0.4 - 1.00
a(+) present; (-) absent.
blogmijkl= A + X- + XR + XA + X'[A,B,C,D].
Xjl+ C XI+ 41+ AC B I+jCk BD CDl 0log mijkl = g + B + A+ , + XCD [AB,AC,AD,BC,BD,CD].
~~~~~~~~XB C+X XA +X + ?4ICk + X4ID + XCD + XABC + XAB~D[DACBD 109 Mijkl = + At +A+ Ak + 'Li +A ik + ii + g v kl + ijk + jl [CD,ABC,ABD].
Table 4. Parameter estimates [ = exp (A)] of log-linear models.
Combination of abnormalitiesa Model lb Model 80C Model 113d Model 103'
[A] (+8) 0.747 1.065 1.188 1.208
[B] (+Ph') 0.714 0.675 0.698 0.676
[C] (i(17q)) 0.596 0.395 0.385 0.378
[D] (+19) 0.433 0.380 0.382 0.371
[AB] (+8) x (+Ph') 1.081 1.115 1.124
[AC] (+8) x (i(17q)) 1.194* 1.291 1.317
[AD] (+8) x (+19) 1.463* 1.475 1.498
[BC] (+Ph') x (i(17q)) 0.630* 0.639 0.617
[BD] (+Ph') x (+19) 1.384* 1.473 1.412
[CD] (i(17q)) x (+19) 0.762* 0.771 0.750
[ABC] (+8) x (+Ph') x (i(17q)) 1.125 1.132
[ABD] (+8) x (+Ph') x (+19) 0.909 0.915
[ACD] (+8) x (i(17q)) x (+19) 0.982
[BCD] (+Ph') x (i(17q)) x (+19) 1.053
Value ofAICf 188.49 - 3.69 - 1.99 - 5.68
Order of AIC from 113 5 13 1
the minimum value
aFactors A, B, C, and D represent the categorical (none or present variables, where A: 8, B: +Ph', C:i(17q), D: + 19.
b[A,B,C,D].
![AB,AC,AD,BC,BD,CD].
g iakl Ai +AjB + AC + AD + X4B + XAC + XAD + XjBC + AjBD + XCD + XABC +XAPD +ABD D +BD
[ABC,ABD,ACD,BCD].
e[CD,ABC,ABD].
'AIC = Akaike's information criteria.
*p < 0.001.
is explained only by the interactions oftwo factors, such
as '+8and +Ph"1, '+8and + 19', and '+Ph' and + 19'.
The interaction ofthree factors such as ' +8, +Ph', and
+ 19' would not be necessary.
Figure 1 schematically shows the route ofkaryotypic
evolution in Ph'-positive CML inferred by our analysis.
That is, after atranslocation 9;22 occurs, one ofthe four
abnormalities, +Ph', +8, i(17q), or + 19, appears alone
at first then the combinations of two abnormalities
'+Ph' and +8', '+Ph' and +19', '+8 and +19', '+8
and i(17q)', '+Ph' and i(17q)', or '+ 19 and i(17q)' ap-
pears in the next step. However, the degree of asso-
ciation differ in their combinations: '+Ph1 and + 19',
' +8 and + 19', and ' +8 and i(17q)' were positively as-
sociated, while '+Ph' and i(17q)' and '+ 19 and i(17q)'
were negatively associated. Furthermore, the third ab-
normality can be added to the previously formed combi-
nation ofthe two abnormalities (Tables 3,4 and Fig. 1).
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| Ph'negative ||46, Ph' ||46,variant transl.|
I
Further karyotypic change
/f-------------- --
|+Ph' +8 | +|Ph' +1||*8, +19 | |+8, i(17q) +Ph' ,i(17q) | | 19, i 17q)|
I ~ ~~~ I
II
| +Ph' , +8, +19 || +Ph', +8, MW7) +8, +19, i(17q) || +Ph', +19, i(17q)|
FIGURE 1. Karyotypic evolution in CML. After a translocation 9;22 occurs, one ofthe four abnormalities, +Ph', +8, i(17q), or +19 appears
alone at first; then the combinations of two abnormalities '+Ph' and +8', '+Ph' and +19', '+8 and +19', '+8 and i(17q)', '+Ph' and
i(17q)', or '+19 and i(17q)' appears in the next step. However, the frequencies differ in their combinations, e.g., predominant in '+Ph'
and + 19' or ' +8 and i(17q)' and rare in '+Ph1 and i(17q)'; furthermore, the third abnormality can be added to the combination ofthe two
abnormalities.
Our findings obtained from analyzing the multiway
contingency table with respect to the four additional
abnormalities statistically support the hypothesis of
karyotypic evolution in CML presented by Heim and
Mitelman (4). However, our results are derived only
from the log-linear analysis. In the next step other
methods, such as corresponded analysis orfactor analy-
sis, etc., should be applied for the same data set to
complement our present analysis. Because the previ-
ously mentioned hypothesis results from the analysis
based on the karyotypes in a given stage, time-series
data analysis ofkaryotypes from a single patient is also
necessary to confirm the hypothesis.
Generally, chromosomal abnormalities of neoplastic
cells canbedividedintotwogroups (1). Oneisaprimary
abnormality that specifically appears in the initiation of
the malignant process. Inthe case ofCML, itis atrans-
location of9;22. The other is an additional abnormality
that appears during the clonal evolution of neoplastic
cells, such as +8, +Ph1, and i(17q) in CML. The pri-
mary chromosomal changes result in the relocation of
cellular oncogenes (12). In the initiation of CML, the
cellular oncogene c-abl mapped on the chromosome 9
band q34, which is normally expressed as 6.0-7.0kb
mRNA, and the protein P145abl is relocated to the bcr
gene mapped on the chromosome 22 band qll (13-15).
This event leads to the expression ofrearranged genes
and their products, that is 8.5 kb mRNA and protein
P210bcr-abl, respectively (16). The abnormal protein
with tyrosine kinase activity would probably make cells
acquire a proliferative ability. On the other hand, ad-
ditional chromosome abnormalities relate to the regu-
lation ofproliferation and/ordifferentiationthrough loss
orinactivation ofthegenesandunbalanceofthegenome
derived from gene amplification. Thus, additional chro-
mosomal changes contribute to the acceleration of the
malignancy of the disease. The analysis of the pattern
of additional abnormalities, therefore, would give an
important clue to the estimation ofpathophysiology and
prognosis of CML patients.
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